Gonzalez F - Search Results

1

MicroRNA Profiling of B Cell Subsets from Systemic Lupus Erythematosus Patients Reveals Promising Novel Biomarkers.

Duroux-Richard I, Cuenca J, Ponsolles C, Piñeiro AB, Gonzalez F, Roubert C, Areny R, Chea R, Pefaur J, Pers YM, Figueroa FE, Jorgensen C, Khoury M, Apparailly F. Duroux-Richard I, et al. Among authors: gonzalez f. Int J Mol Sci. 2015 Jul 27;16(8):16953-65. doi: 10.3390/ijms160816953. Int J Mol Sci. 2015. PMID: 26225955 Free PMC article.

2

Adipose tissue-derived mesenchymal stromal cells for treating chronic kidney disease: A pilot study assessing safety and clinical feasibility.

Villanueva S, González F, Lorca E, Tapia A, López VG, Strodthoff R, Fajre F, Carreño JE, Valjalo R, Vergara C, Lecanda M, Bartolucci J, Figueroa FE, Khoury M. Villanueva S, et al. Among authors: gonzalez f. Kidney Res Clin Pract. 2019 Jun 30;38(2):176-185. doi: 10.23876/j.krcp.18.0139. Kidney Res Clin Pract. 2019. PMID: 31189223 Free PMC article.

3

Identifying Factors Predicting Kidney Graft Survival in Chile Using Elastic-Net-Regularized Cox's Regression.

Magga L, Maturana S, Olivares M, Valdevenito M, Cabezas J, Chapochnick J, González F, Kompatzki A, Müller H, Pefaur J, Ulloa C, Valjalo R. Magga L, et al. Among authors: gonzalez f. Medicina (Kaunas). 2022 Sep 26;58(10):1348. doi: 10.3390/medicina58101348. Medicina (Kaunas). 2022. PMID: 36295509 Free PMC article.

4

Clinical Efficacy of SARS-CoV-2 Vaccination in Hemodialysis Patients.

Torres R, Toro L, Sanhueza ME, Lorca E, Ortiz M, Pefaur J, Clavero R, Machuca E, Gonzalez F, Herrera P, Mocarquer A, Frias A, Roessler E, Muñoz C, Nuñez M, Aravena C, Quintana E, Lemus J, Lillo M, Reynolds E, Morales A, Pais E, Fiabane A, Parra-Lucares A, Garrido C, Mendez-Valdes G, Villa E, Mansilla R, Sotomayor G, Gonzalez M, Miranda C, Briones E, Gomez E, Mezzano S, Bernales W, Rocca X, Espinoza O, Zuñiga E, Aragon H, Badilla M, Valenzuela M, Escobar L, Zamora D, Flores I, Tapia B, Borquez T, Herrera P. Torres R, et al. Among authors: gonzalez f, gonzalez m. Kidney Int Rep. 2022 Oct;7(10):2176-2185. doi: 10.1016/j.ekir.2022.07.007. Epub 2022 Jul 16. Kidney Int Rep. 2022. PMID: 35874643 Free PMC article.

5

Effectiveness and cost of replacing a calcineurin inhibitor with sirolimus to slow the course of chronic kidney disease in renal allografts.

González F, Espinoza M, Reynolds E, Herrera P, Espinoza O, Rocca X, Lorca E, Hidalgo J, Roessler E. González F, et al. Transplant Proc. 2010 Jan-Feb;42(1):284-7. doi: 10.1016/j.transproceed.2009.12.049. Transplant Proc. 2010. PMID: 20172332

6

Everolimus versus azathioprine in a cyclosporine and ketoconazole-based immunosuppressive therapy in kidney transplant: 3-year follow-up of an open-label, prospective, cohort, comparative clinical trial.

Gonzalez F, Espinoza M, Herrera P, Rocca X, Reynolds E, Lorca E, Roessler E, Hidalgo J, Espinoza O. Gonzalez F, et al. Transplant Proc. 2010 Jan-Feb;42(1):270-2. doi: 10.1016/j.transproceed.2009.12.048. Transplant Proc. 2010. PMID: 20172327 Clinical Trial.

7

[Young woman, daughter of a father with Alports syndrome, debuts with a impure nephrotic syndrome].

González F, Méndez G, Navarrete D, Roessler B E. González F, et al. Rev Med Chil. 2017 May;145(5):623-629. doi: 10.4067/S0034-98872017000500010. Rev Med Chil. 2017. PMID: 28898339 Free article. Spanish. No abstract available.

8

Empirical or unconscious reduction of the secondary immunosuppressive drug concomitantly with intended calcineurin inhibitor reduced exposure to improve kidney graft function can be followed by antibody mediated rejections.

Gonzalez F. Gonzalez F. Clin Transplant. 2015 Apr;29(4):277-8. doi: 10.1111/ctr.12512. Epub 2015 Feb 27. Clin Transplant. 2015. PMID: 25721942 No abstract available.

9

Is the near coming xenotransplantation era relieving us from needing to look for more non-living organ donors?

Gonzalez FM, Gonzalez FDR. Gonzalez FM, et al. World J Transplant. 2022 Dec 18;12(12):388-393. doi: 10.5500/wjt.v12.i12.388. World J Transplant. 2022. PMID: 36570406 Free PMC article.

10

Conversion from Sandimmune to Neoral in renal transplant: functional histopathological, and pharmacokinetic changes.

Roessler E, Herrera S, Espinoza M, Ayala A, Reynolds E, González F, Espinoza O, Undurraga A, Muñoz R, Arcos O, Galaz G. Roessler E, et al. Among authors: gonzalez f. Transplant Proc. 1998 Aug;30(5):1756-7. doi: 10.1016/s0041-1345(98)00417-5. Transplant Proc. 1998. PMID: 9723268 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,726 results

Search Page

Filters